GrowingStockReport.com

NASDAQ Gainers Watch List: Venaxis, Inc. (NASDAQ:APPY) and MEI Pharma, Inc. (NASDAQ:MEIP) Added to Growing Stock Report's NASDAQ Gainers Watch List

 

New York, NY -- (ReleaseWire) -- 02/25/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Venaxis, Inc. (NASDAQ:APPY) and MEI Pharma, Inc. (NASDAQ:MEIP)

Venaxis, Inc. (NASDAQ:APPY) a company that operates as a biomedical company in the United States and its research and development activities primarily focus on a human acute appendicitis blood-based test is currently up (+22.48%) on 881,854 shares traded after Venaxis upgraded to Buy from Hold at Canaccord. Venaxis, Inc. (NASDAQ:APPY) is currently up (+124.58%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Venaxis, Inc. (NASDAQ:APPY)

MEI Pharma, Inc. (NASDAQ:MEIP) a development stage oncology company that focuses on the clinical development of therapeutics for the treatment of cancer is currently up (+1.27%) on 39,635 shares traded. MEI Pharma, Inc. (NASDAQ:MEIP) is currently up (+288.89%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about MEI Pharma, Inc. (NASDAQ:MEIP)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com